Statement of Changes in Beneficial Ownership (4)
December 05 2022 - 4:25PM
Edgar (US Regulatory)
FORM 4
[ ]
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
|
OMB APPROVAL
OMB Number:
3235-0287
Estimated average burden hours per response...
0.5
|
|
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940
|
|
1. Name and Address of Reporting Person
*
Foresite Capital Management V, LLC |
2. Issuer Name and Ticker or Trading Symbol
PARDES BIOSCIENCES, INC.
[
PRDS
]
|
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
_____ Director __X__ 10% Owner _____ Officer (give title below) _____ Other (specify below)
|
(Last)
(First)
(Middle)
900 LARKSPUR LANDING CIRCLE, SUITE 150, |
3. Date of Earliest Transaction
(MM/DD/YYYY)
12/1/2022 |
(Street)
LARKSPUR, CA 94939
(City)
(State)
(Zip)
|
4. If Amendment, Date Original Filed
(MM/DD/YYYY)
|
6. Individual or Joint/Group Filing
(Check Applicable Line)
___ Form filed by One Reporting Person
_
X
_ Form filed by More than One Reporting Person
|
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
|
1.Title of Security (Instr. 3)
|
2. Trans. Date
|
2A. Deemed Execution Date, if any
|
3. Trans. Code (Instr. 8)
|
4. Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)
|
5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)
|
6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)
|
7. Nature of Indirect Beneficial Ownership (Instr. 4)
|
Code
|
V
|
Amount
|
(A) or (D)
|
Price
|
Common Stock | 12/1/2022 | | P | | 637420 | A | $0.85 | 12809810 | I | See Footnote (1) |
Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
|
1. Title of Derivate Security (Instr. 3) | 2. Conversion or Exercise Price of Derivative Security | 3. Trans. Date | 3A. Deemed Execution Date, if any | 4. Trans. Code (Instr. 8) | 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) | 6. Date Exercisable and Expiration Date | 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) | 8. Price of Derivative Security (Instr. 5) | 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) | 10. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 4) | 11. Nature of Indirect Beneficial Ownership (Instr. 4) |
Code | V | (A) | (D) | Date Exercisable | Expiration Date | Title | Amount or Number of Shares |
Explanation of Responses: |
(1) | On December 1, 2022, Foresite Capital Fund V, L.P. ("Capital Fund V L.P.") purchased 637,420 shares of the Issuer's Common Stock at an aggregate price of approximately $0.85 per share, or $541,807 in the aggregate, in open market purchases. Foresite Capital Management V, LLC ("FCMVLLC") is the general partner of Capital Fund V L.P. Each of FCMVLLC and Dr. Tananbaum, in his capacity as managing member of FCMVLLC, disclaims beneficial ownership of these shares except to the extent of any pecuniary interest therein. |
Reporting Owners
|
Reporting Owner Name / Address | Relationships |
Director | 10% Owner | Officer | Other |
Foresite Capital Management V, LLC 900 LARKSPUR LANDING CIRCLE, SUITE 150 LARKSPUR, CA 94939 |
| X |
|
|
Tananbaum James B. C/O PARDES BIOSCIENCES, INC. 2173 SALK AVE, SUITE 250, PMB#052 CARLSBAD, CA 92008 | X | X |
|
|
Foresite Capital Fund V, L.P. 900 LARKSPUR LANDING CIRCLE, SUITE 150 LARKSPUR, CA 94939 |
| X |
|
|
Signatures
|
/s/ Dennis Ryan, on behalf of Foresite Capital Management V, LLC | | 12/5/2022 |
**Signature of Reporting Person | Date |
/s/ Elizabeth Lacy, Attorney-in-Fact for James B. Tananbaum | | 12/5/2022 |
**Signature of Reporting Person | Date |
/s/ Dennis Ryan, on behalf of Foresite Capital Fund V, L.P. | | 12/5/2022 |
**Signature of Reporting Person | Date |
/s/ Dennis Ryan, as Attorney-in-Fact for Foresite Capital Fund V, L.P. and Foresite Capital Management V, LLC | | 12/5/2022 |
**Signature of Reporting Person | Date |
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly. |
* | If the form is filed by more than one reporting person, see Instruction 4(b)(v). |
** | Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a). |
Note: | File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure. |
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number. |
FS Development Corporati... (NASDAQ:FSII)
Historical Stock Chart
From Jun 2024 to Jul 2024
FS Development Corporati... (NASDAQ:FSII)
Historical Stock Chart
From Jul 2023 to Jul 2024